Dermatologic aspects of Antiphospholipid Antibody Syndrome

Handbook of Systemic Autoimmune Diseases

Volumn 5, Issue , 2006, Pages 103-117

  Frances, Camille ^a   Piette, Jean Charles ^a   Asherson, Ronald A ^b,c  

^a Department of Dermatology Allergology ^*  (France)

^b Biblioteca de Catalunya Hospital   (Spain)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34147201857     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(05)05009-9     Document Type: Review

References (101)

1. Alarcon-Segovia D., Delezé M., Oria C.V., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 68 (1989) 353
2. Alarcon-Segovia D., Perez-Vazquez M.E., Villa A.R., et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin. Arthritis Rheum. 21 (1992) 275
3. Alegre V.A., and Winkelmann R.K. Histopathologic and immunofluorescence study of skin lesions associated with circulating anticoagulant. J. Am. Acad. Dermatol. 19 (1988) 117
4. Ames D.E., Asherson R.A., Ayres B., et al. Bilateral adrenal infarction, hypoadrenalism and splinter haemorrhages in the primary antiphospholipid syndrome. Br. J. Rheumatol. 31 (1992) 117
5. Asherson R.A. Subungual splinter haemorrhages: a new sign of antiphospholipid coagulopathy?. Ann. Rheum. Dis. 49 (1990) 268
6. Asherson R.A. The catastrophic antiphospholipid syndrome. J. Rheumatol. 19 (1992) 508
7. Asherson R.A., and Cervera R. The antiphospholipid syndrome: a syndrome in evolution. Ann. Rheum. Dis. 51 (1992) 147
8. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195
9. Asherson, R.A., Cervera, R., Piette, J.C., et al. 2001. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80, 355. Largest series on catastrophic APS.
10. Asherson R.A., Derksen R.H.W.M., Harris E.N., et al. Large vessel occlusion and gangrene in systemic lupus erythematosus and lupus-like disease: a report of 6 cases. J. Rheumatol. 13 (1986) 740
11. Asherson R.A., and Hughes G.R.V. Recurrent deep vein thrombosis and Addison's disease in primary antiphospholipid syndrome. J. Rheumatol. 16 (1989) 378
12. Asherson R.A., Jacobelli S., Rosenberg H., et al. Skin nodules and macules resembling vasculitis in the antiphospholipid syndrome. Clin. Exp. Dermatol. 17 (1992) 266
13. Asherson R.A., and Khamashta M.A. Sneddon's syndrome and the primary antiphospholipid syndrome. Br. J. Dermatol. 122 (1990) 115
14. Asherson R.A., Khamashta M.A., Ordi-Ros J., et al. The primary antiphospholipid syndrome: major clinical and pathological features. Medicine 68 (1989) 366
15. Asherson R.A., Mayou S.C., Merry P., et al. The spectrum of livedo reticularis and anticardiolipin antibodies. Br. J. Dermatol. 120 (1989) 215
16. Assier H., Chosidow O., Piette J.C., et al. Absence of antiphospholipid antibodies and anti-endothelial cell antibodies in malignant atrophic papulosis. J. Am. Acad. Dermatol. 33 (1995) 831
17. Balada E., Ordi-Ros J., Paredes F., et al. Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. Scand. J. Rheumatol. 30 (2001) 235
18. Bessis D., Sotto A., Viard J.P., et al. Trousseau's syndrome with nonbacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome. Am. J. Med. 98 (1995) 511
19. Black M.M., and Hudson P.M. Atrophie blanche lesions closely resembling malignant atrophic papulosis (Degos' disease) in systemic lupus erythematosus. Br. J. Dermatol. 95 (1976) 649
20. Bowie E.J.W., Thompson J.H., Pascuzzi C.A., et al. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J. Lab. Clin. Med. 62 (1963) 416
21. Brandt J.T., Triplett D.A., Alving B., et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the subcommittee for the standardization of lupus anticoagulants. Thromb. Haemost. 74 (1995) 1185
22. Burton, J.L. 1988. Livedo reticularis, porcelain-white scars and cerebral thrombosis. Lancet I, 1263.
23. Cervera R., Asherson R.A., Acevedo M.L., et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann. Rheum. Dis. 63 (2004) 1312
24. Cervera, R., Piette, J.C., Font, J., et al. 2002. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46, 1019. Largest European series on APS
25. Chacek S., Mac-Gregor-Gooch J., Halabe-Cherem J., et al. Pyoderma gangrenosum and extensive caval thrombosis associated with antiphospholipid syndrome-a case report. Angiology 49 (1998) 157
26. Combemale P., Amiral J., Estival J.L., et al. Cutaneous necrosis revealing the coexistence of an antiphospholipid syndrome with acquired protein S deficiency, factor V Leiden and hyperhomocysteinemia. Eur. J. Dermatol. 12 (2002) 278
27. Creamer D., Black M.M., and Calonje E. Reactive angioendotheliomatosis in association with the antiphospholipid syndrome. J. Am. Acad. Dermatol. 42 (2000) 903
28. Creamer D., Hunt B.J., and Black M.M. Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: a report of two cases. Br. J. Dermatol. 142 (2000) 1199
29. Del Castillo L.E., Soria C., Schoendorff C., et al. Widespread cutaneous necrosis and antiphospholipid antibodies: two episodes related to surgical manipulation and urinary tract infection. J. Am. Acad. Dermatol. 36 (1997) 872
30. Dessein P.H., Lamparelli R.D., Phillips S.A., et al. Severe immune thrombocytopenia and the development of skin infarctions in a patient with an overlap syndrome. J. Rheumatol. 16 (1989) 1494
31. Disdier P., Harlé J.R., Andrac L., et al. Primary anetoderma associated with the antiphospholipid syndrome. J. Am. Acad. Dermatol. 30 (1994) 133
32. Dodd H.J., Sarkany I., and O'Shaugnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin. Exp. Dermatol. 10 (1985) 581
33. Doutre M.S., Beylot C., Bioulac P., et al. Skin lesion resembling malignant atrophic papulosis in lupus erythematosus. Dermatologica 175 (1987) 45
34. Dublin H.V., and Stawiski M.A. Systemic lupus erythematosus resembling malignant atrophic papulosis. Arch. Int. Med. 134 (1974) 321
35. Edwards M.H., Pierangeli S., Liu X., et al. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 96 (1997) 4380
36. Englert H.J., Loizou S., Derue G.G.M., et al. Clinical and immunologic features of livedo reticularis in lupus: a case-control study. Am. J. Med. 87 (1989) 408
37. Farrant J.M., Judje M., and Thompson R.P.H. Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome. Clin. Exp. Dermatol. 14 (1989) 306
38. Farrell A.M., Moss J., Costello C., et al. Benign cutaneous degos' disease. Br. J. Dermatol. 139 (1998) 708
39. Finazzi G., Marchioli R., Brancaccio V., et al. A randomized trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J. Thromb. Haemost. 3 (2005) 848
40. Flamholz R., Tran T., Grad G.I., et al. Therapeutic plasma exchange for the acute management of the catastrophic antiphospholipid syndrome: beta(2)-glycoprotein I antibodies as a marker of response to therapy. J. Clin. Apheresis 14 (1999) 171
41. Fraga A., and Mintz G. Splinter haemorrhages in SLE. Arthritis Rheum 9 (1966) 648
42. Francès C., and Barete S. Difficult management of livedoid vasculopathy. Arch. Dermatol. 140 (2004) 2011
43. Frances C., Blétry O., and Piette J.C. Dermatologic manifestations in the antiphospholipid syndrome. In: Asherson R.A., Cervera R., Piette J.C., and Shoenfeld Y. (Eds). The Antiphospholipid Syndrome (1996), CRC Press, Boca Raton, FL 201
44. Frances, C., Niang, S., Laffitte, E., et al. 2005. Dermatologic manifestations of antiphospholipid syndrome. Two hundred consecutive cases. Arthritis Rheum 52, 1785. Largest dermatologic series.
45. Francès C., Papo T., Wechsler B., et al. Sneddon syndrome with or without antiphospholipid antibodies: a comparative study in 46 patients. Medicine (Baltimore) 78 (1999) 209
46. Francès C., and Piette J.C. Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus. Lupus 6 (1997) 139
47. Francès C., Piette J.C., Saada V., et al. Multiple subungual splinter hemorrhages in the antiphospholipid syndrome. A report of five cases and review of the literature. Lupus 3 (1994) 123
48. Francès C., Tribout B., Boisnic S., et al. Cutaneous necrosis associated with the lupus anticoagulant. Dermatologica 178 (1989) 194
49. Galli M., and Barbui T. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin. Thromb. Hemost. 31 (2005) 17
50. Gertner E. Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome. Lupus 12 (2003) 133
51. Gertner E., and Lie J.T. Systemic therapy with fibrinolytic agents and heparin for recalcitrant nonhealing cutaneous ulcer in the antiphospholipid syndrome. J. Rheumatol. 21 (1994) 2159
52. Golden A.L. Livedo reticularis in systemic lupus erythematosus. Arch. Dermatol. 87 (1963) 299
53. Grattan C.E.H., Burton J.L., and Boon A.P. Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies. Br. J. Dermatol. 120 (1989) 441
54. Grob J.J., and Bonerandi J.J. Thrombotic skin disease as a marker of the anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J. Am. Acad. Dermatol. 20 (1989) 1063
55. Grob J.J., San Marco M., Aillaud M.F., et al. Unfading acral microlivedo: a discrete marker of thrombotic skin disease associated with antiphospholipid antibody syndrome. J. Am. Acad. Dermatol. 24 (1991) 53
56. Harris E.N., Baguley E., Asherson R.A., et al. Clinical and serological features of the antiphospholipid syndrome (abstract). Br. J. Rheumatol. 26 (1987) 19
57. Hughes G.R.V. Connective tissue disease and the skin. The prosser-white oration 1983. Clin. Exp. Dermatol. 9 (1984) 535
58. Ingram S.B., Goodnight S.H., and Bennett R.M. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. Arthritis Rheum 30 (1987) 1167
59. Ishikawa O., Takahashi A., Tamura A., et al. Cutaneous papules and nodules in the diagnosis of antiphospholipid syndrome. Br. J. Dermatol. 140 (1999) 725
60. Jindal B.K., Martin M.F.R., and Gayner A. Gangrene developing after minor surgery in a patient with undiagnosed systemic lupus and lupus anticoagulant. Ann. Rheum. Dis. 42 (1983) 347
61. Kalashnikova L.A., Nasonov E.L., Stoyanovich L.Z., et al. Sneddon's syndrome and the primary antiphospholipid syndrome. Cerebrovasc. Dis. 4 (1994) 76
62. Khamashta M.A. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies. J. Autoimmun. 15 (2000) 249
63. Levine S.R., Langer S.L., Albers J.W., et al. Sneddon'syndrome: an antiphospholipid antibodies syndrome. Neurology 38 (1988) 798
64. Lie J.T. Vasculitis in the antiphospholipid syndrome: culprit or consort?. J. Rheumatol. 21 (1994) 397
65. Marechal V., De Maistre E., Barbaud A., et al. Résistance à la protéine C activée et anticorps anticardiolipine dans les ulcères de jambes. Ann. Dermatol. Venereol. 127 (2000) 585
66. Meroni P.L., Raschi E., Testoni C., et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum 44 (2001) 2870
67. Mc Hugh M.J., Maymo J., Skinner R.P., et al. Anticardiolipin antibodies, livedo reticularis and major cerebrovascular and renal disease in systemic lupus erythematosus. Ann. Rheum. Dis. 47 (1988) 110
68. Moreb J., and Kitchens C.S. Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome. Report of two cases. Am. J. Med. 87 (1989) 207
69. Mujic F., Lloyd M., Cuadrado M.J., et al. Prevalence and clinical significance of subungual splinter hemorrhages in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol. 13 (1995) 327
70. Nahass, G.T. 1997. Antiphospholipid antibodies and the antiphospholipid antibody syndrome. J. Am. Acad. Dermatol. 36, 149. Review on antiphospholipid syndrome in a dermatologic journal.
71. Neuwelt C.M., Daikh D.I., Linfoot J.A., et al. Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum 40 (1997) 1534
72. Nochy D., Daugas E., Droz D., et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J. Am. Soc. Nephrol. 10 (1999) 507
73. O'Neill A., Gatenby P.A., McGaw B., et al. Widespread cutaneous necrosis associated with cardiolipin antibodies. J. Am. Acad. Dermatol. 22 (1990) 356
74. Petri M. Hydroxychloroquine use in the Baltimore lupus cohort: effects on lipids, glucose and thrombosis. Lupus 5 (1996) S16
75. Pierangeli S.S., Stewart M., Silva L.K., et al. Report of an anticardiolipin wet workshop during the VIIth International Symposium on antiphospholipid antibodies. J. Rheumatol. 101 (1998) 616
76. Piette J.C., Cervera R., Levy R.A., et al. The catastrophic antiphospholipid syndrome-Asherson's syndrome. Ann. Med. Interne. 154 (2003) 195
77. Piette J.C., Karmochkine M., Papo T., et al. Treatment of the antiphospholipid syndrome. Clin. Rev. Allergy Immunol. 13 (1995) 73
78. Piette J.C., and Piette A.M. Management of the antiphospholipid syndrome: main trends, unsolved questions, practical and educational aspects. Ann. Med. Interne. 147 Suppl. 1 (1996) 28
79. Piette W.W. Antiphospholipid syndrome: the problems and the promise. Br. J. Dermatol. 142 (2000) 1080
80. PROGRESS Collaborative Group. 2001. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358, 1033.
81. Reber G., and de Moerloose P. Anti-beta2-glycoprotein I antibodies-when and how should they be measured?. Thomb. Res. 114 (2004) 527
82. Renfro L., Franks A.G., Grodberg M., et al. Painful nodules in a young female. Arch. Dermatol. 128 (1992) 847
83. Rocca P.V., Siegel L.B., and Cupps T.R. The concomitant expression of vasculitis and coagulopathy: synergy for marked tissue ischemia. J. Rheumatol. 21 (1994) 556
84. Romani J., Perez F., Llobet M., et al. Anetoderma associated with antiphospholipid antibodies. Case report and review of the literature. J. Eur. Acad. Dermatol. Venereol. 15 (2000) 175
85. Ruffati A., De Silvestro G., Ghirardello A., et al. A catastrophic antiphospholipid syndrome: the importance of high levels of warfarin anticoagulation. J. Intern. Med. 235 (1994) 81
86. Sanmarco M., Bardin N., Blank M., et al. Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results. Thromb. Haemost. 93 (2005) 80
87. Schmid M.H., Hary C., Marstaller B., et al. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome. Eur. J. Dermatol. 8 (1998) 45
88. Smith K.J., Skelton H.G., James W.D., et al. Cutaneous histopathologic findings in antiphospholipid syndrome. Arch. Dermatol. 126 (1990) 1176
89. Sneddon I.B. Cerebrovascular lesions and livedo reticularis. Br. J. Dermatol. 77 (1965) 180
90. Sparsa A., Piette J.C., Wechsler B., et al. Anetoderma and its prothrombotic abnormalities. J. Am. Acad. Dermatol. 49 (2003) 1008
91. Srinivasan S.K., Pittelkow M.R., and Cooper Jr. L.T. Recombinant tissue plasminogen activator for the treatment of cutaneous infarctions in antiphospholipid antibody syndrome: a case report. Angiology 52 (2001) 635
92. Stephansson E.A., and Niemi K.M. Antiphospholipid antibodies and anetoderma; are they associated?. Dermatology 191 (1995) 204
93. Stephansson E.A., Niemi K.M., Jouhikainen T., et al. Lupus anticoagulant and the skin. A long term follow-up study of SLE patients with special reference to histopathological findings. Acta Derm. Venereol. (Stockholm) 71 (1991) 416
94. Tran M.D., Bécherel P.A., Cordel N., et al. Atrophie blanche idiopathique. Ann. Dermatol. Venereol. 128 (2001) 1003
95. Tubach F., Hayem G., Marchand J.L., et al. IgG anti-beta 2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. J. Rheumatol. 27 (2000) 1437
96. Vianna J.L., Khamasta M.A., Ordi-Ros J., et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am. J. Med. 96 (1994) 3
97. Weinstein C., Miller M.H., Axtens R., et al. Livedo reticularis associated with increased titres of anticardiolipin antibodies in systemic lupus erythematosus. Arch. Dermatol. 123 (1987) 596
98. Wilson, W.A., Gharavi, A.E., Koike, T., et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42, 1309. This study established the current classification criteria for definite antiphospholipid syndrome.
99. Wilson W.A., Gharavi A.E., and Piette J.C. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus 10 (2001) 457
100. Zahavi J., Charach G., Schafer R., et al. Ischaemic necrotic toes associated with antiphospholipid syndrome and treated with iloprost (letter). Lancet 342 (1993) 862
101. Zelger B., Sepp N., Stockhammer G., et al. Sneddon's syndrome. A long term follow up of 25 patients. Arch Dermatol 129 (1993) 437